Adenosine regulates the \(Ca^{2+} \) sensitivity of mast cell mediator release : (histamine secretion/inositol phosphates/calcium) by Lohse, Martin J. et al.
Proc. Natl. Acad. Sci. USA 
Vol. 85, pp. 8875-8879, December 1988 
Biochemistry 
Adenosine regulates the Ca2+ sensitivity of mast cell 
mediator release 
(histamine secretion/inositol phosphates/calcium) 
MARTIN J. LOHSE*, KARL-NoRBERT KLOTZ*, MANFRED J. SALZERt, AND ULRICH SCHWABE* 
*Pharmakologisches Institut and tlnstitut fiir Biochemie I, Vniversitat Heidelberg, Im Neuenheimer Feld 366, 6900 Heidelberg, Federal Republic of Germany 
Communicated by Man/red Eigen, August 17, 1988 
ABSTRACT Mast cells release histamine and other medi-
ators of allergy in response to stimulation of their IgE recep-
tors. This release is generally thought to be mediated by an 
elevation of cytosolic Ca2+ . Recent evidence suggests that there 
might be factors that modulate the coupling between Ca2+ 
levels and mediator release. The present report identifies 
adenosine as one such modulator. Adenosine and several of its 
metabolically stable analogues were shown to enhance hista-
mine release from rat peritoneal mast cells in response to 
stimuli such as concanavalin A. Metabolizing endogenous 
adenosine with adenosine deaminase dampened the response to 
stiniuli, whereas trapping endogenous adenosine inside mast 
cells with nucleoside-transport inhibitors markedly enhanced 
stimulated histamine release. The metabolically stable adeno-
sine analogue 5' -(N-ethylcarboxamido)adenosine (NECA) did 
not affect the initial steps in the sequence from IgE-receptor 
activation to mediator release, which are generation of inositol 
trisphosphate and increase of cytosolic Ca2+ . However, NECA 
did enhance the release induced in ATP-permeabilized cells by 
exogenous Ca2+, but it had no effect on the release induced by 
phorbol esters. These data suggest that adenosine sensitizes 
mediator release by a mechanism regulating stimulus-secretion 
coupling at a step distal to receptor activation and second-
messenger generation. 
Bridging of mast cell IgE receptors by divalent antigen, Con 
A, or by chemically oligomerized IgE stimulates a sequence 
of events resulting in degranulation of the cells and release of 
allergy mediators such as histamine (1). IgE-receptor stimu-
lation in different cells has been demonstrated to generate 
inositol trisphosphate (lnsP3) from phosphatidylinositol 4,5-
bisphosphate (2, 3) and to elevate levels of cytosolic Ca2+ (2, 
4). Although some authors (1) regard an elevation of cytosolic 
Ca2+ levels as being essential and sufficient for mediator 
release, in experiments with single cells Ca2+ levels and 
exocytosis did not necessarily correlate (5). Thus coupling of 
Ca2+ levels to mediator release may itself be subject to 
regulation (6). From experiments with permeabilized neutro-
phils, a role for guanine nucleotides in regulating secretion at 
a site distal to elevated cytosolic Ca2+ was proposed (7). 
Adenosine has been shown to enhance histamine release 
from mast cells in response to different stimuli (8), an effect 
attributed to action at specific membrane-bound receptors 
(8-10). However, more recently we showed that blockade of 
the nucleoside transporter abolishes the effect of exogenous 
adenosine, and we hence concluded that adenosine exerts its 
effects on histamine release intracellularly (11). The present 
study investigates this intracellular mechanism by which 
adenosine affects histamine release from mast cells. 
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MATERIALS AND METHODS 
Materials. myo-[2-3H(N)]lnositol (16.5 Ci/mmol; 1 Ci = 37 
GBq) was obtained from New England Nuclear. Quin-2 
tetrakis(acetoxymethy!) ester was purchased from Calbio-
chem and 413-phorbol, phorbol 12-myristate 13-acetate 
(PMA), and S-(p-nitrobenzy!)-6-thioinosine were purchased 
from Sigma. Adenosine analogues were from Boehringer 
Mannheim. Other materials were obtained from the sources 
described earlier (11, 12). 
Purification of Mast Cells. Peritoneal mast cells were 
obtained by peritoneal lavage from male Wistar rats of 200-
300 g. The cells were purified to >95% homogeneity by 
centrifugation with Percoll as described (11). Unless stated 
otherwise, cells were resuspended in a buffer containing 137 
mM NaCl, 2.7 mM KCl, 1.0 mM CaCI2, 0.5 mM MgCI2, 0.4 
mM NaH2P04 , 5.5 mM glucose, 10 mM Hepes, and 0.05% 
bovine serum albumin, pH 7.4 (buffer A). 
Histamine Release Measurement. Histamine release from 
purified rat peritoneal mast cells was measured using 40,000 
cells per ml as outlined (11). In brief, purified cells were 
preincubated at 37°C with all compounds for 10 min before 
the initiation of the release stimulus. After 10 min of incu-
bation (unless stated otherwise) the reaction was stopped, 
and histamine in the supernatant and the cells was deter-
mined by a fluorometric assay. 
Inositol Phosphate Measurement. The generation of inositol 
phosphates was measured in the absence oflithium according 
to Nakamura and Vi (3). Mast cells (6 x 106/m!) were labeled 
with [3H]inositol (150 jLCi/ml) for 2 hr at 37°C, washed in the 
presence of 10 mM inositol, and preincubated for 10 min at 
37°C with or without 10 jLM 5'-(N-ethylcarboxamido)-
adenosine (NECA). The content of [3H]inositol phosphates 
(of 5 x 105 cells per tube) was determined under basal 
conditions or 10 sec after addition of Con A at 100 jLg/ml. 
Measurement of Intracellular Ca2+. Initial studies measur-
ing the cytosolic Ca2+ levels with the fluorescent indicator 
fura-2 confirmed the observation (13) that a large proportion 
of the dye accumulated in the granules. The extracellular 
fluorescence caused by fura-2 released from the granules was 
shown by marked and rapid quenching of the signal upon 
addition of 1 mM MnCl2 (14). Loading cells with small 
amounts of quin-2 (15) largely circumvented this problem; 
cells (106/ml) were loaded with 20 jLM quin-2 tetrakis(ace-
toxymethy!) ester at 37°C for 10 min and then for an additional 
20 min after a 10-fold dilution. Two washing steps preceded 
the measurement of fluorescence on 3 x 105 cells containing 
"'='0.2 nmol of quin-2 in a photon-counting spectrofluorometer 
(model 8000; SLM Instruments, Urbana, MA) that had a 
temperature-controlled (37°C) cuvette and a magnetically 
driven stirrer; excitation wavelength was 339 ± 4 nm, and 
emission wavelength was 492 ± 4 nm. Data were corrected 
for extracellular fluorescence of quin-2, which was estimated 
Abbreviations: InsP3 , inositol trisphosphate; NECA, 5'-(N-
ethylcarboxamido)adenosine; PMA, phorbol12-myristate 13-acetate. 
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before and 60 sec after addition of Con A by adding 1 mM 
MnCl2 to separate control samples. Ca2+ levels were calcu-
lated as in ref. 15 by adding 0.2% Triton X-lOO for the 
maximal fluorescence measurement (F max) and stepwise 
addition of EGTA at the end of each experiment. 
Mast Cell Permeabilization. Purified mast cells were per-
meabilized with ATP as described by Bennett et al. (16). 
Purified cells were washed with buffer A supplemented with 
6 mM HEDTA [N-(2-hydroxyethyl)ethylenediaminetriacetic 
acid] but without CaCh and MgCl2 (buffer B). Cells were 
preincubated for 10 min in buffer B with or without 10 ILM 
NECA. Release of histamine was initiated by addition of ATP 
to a final concentration of 3 ILM and different concentrations 
of CaCl2 in buffer B. Free Ca2+ concentrations were calcu-
lated according to Fabiato and Fabiato (17) using the disso-
ciation constants for HEDTA from Martell and Smith (18). 
Histamine release was measured 10 min after the addition of 
Ca2+ and ATP. 
RESULTS 
Adenosine has previously been shown to enhance histamine 
release from purified rat peritoneal mast cells when these are 
stimulated with Con A (11). This effect was found to be 
shared by analogues of adenosine substituted in the N 6_, 2-, 
or 5'-positions: The release in the presence of Con A (0.1 
mg/ml) was enhanced from 20% of total histamine content to 
40-45% by NECA, R-N6-phenylisopropyladenosine, 2-
chloroadenosine, and adenosine itself with ECso values of 0.2 
ILM, 0.3 ILM, 0.4 ILM, and 1.1 ILM, respectively (data not 
shown). 
A similar enhancing effect was seen by trapping endoge-
nous adenosine inside the mast cells; this can be achieved 
with nucleoside-transport inhibitors that inhibit diffusion of 
adenosine into and out of cells (19). S-(p-nitrobenzyl)-
6-thioinosine, a potent nucleoside-transport inhibitor, had no 
effect on basal release (Fig. 1). However, histamine release 
stimulated to high levels by the calcium ionophore A23187 
was potentiated by the presence of the transport inhibitor (P 
< 0.01), suggesting an enhancement by endogenous intracel-
lular adenosine. 
Increased extracellular concentrations of adenosine have 
been seen upon mast cell stimulation (20). Due to rapid 
equilibration via the nucleoside transporter this effect is most 
likely accompanied by increased intracellular adenosine 
concentrations. To assess the contribution of this endoge-
nous adenosine to the stimulation of histamine release we 
added adenosine deaminase at the beginning of the prein-
cubation period (Table 1). The presence of adenosine dea-
minase did not affect basal histamine release. However, it 
reduced histamine release in the presence of Con A (0.1 
mg/ml) and even more so upon stronger stimulation by the 
calcium ionophore A23187. To reduce the interference by 
endogenous adenosine all subsequent experiments were done 
with adenosine deaminase at 2 units per ml and with the 
metabolically stable adenosine analogue NECA. 
Fig. 2 shows the time course ofthe effects of NE CA on Con 
A-induced histamine release. Preincubation with NECA did 
not affect histamine release from mast cells under basal 
conditions but led to a rapid and marked enhancement of 
release after Con A stimulation. This effect was seen imme-
diately after stimulation of release and had a similar extent at 
all time points. Furthermore, it was apparent at all effective 
concentrations of Con A (Fig. 2 Inset). 
However, NECA produced no alterations of the first steps 
subsequent to IgE-receptor stimulation-i.e., stimulation of 
inositol phosphate generation and elevation of cytosolic Ca2+ 
concentrations (Fig. 3). Under basal conditions 10 ILM NECA 
had no significant effect on the levels of InsP3, inositol 
bisphosphate, or inositol monophosphate. Con A increased 
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FIG. 1. Effect of S-(p-nitrobenzyl)-6-thioinosine on basal and 
stimulated histamine release from rat peritoneal mast cells. Mast 
cells were preincubated for 10 min with (shaded bars) or without 
(open bars) 1 ILM S-(p-nitrobenzyl)-6-thioinosine, and the release 
was measured 10 min after addition of 0.35 ILM calcium ionophore 
A23187 or buffer. Data are presented as the mean and SEM from 
three independent experiments for each condition. 
the levels of InsP3 (and inositol bisphosphate) =2-fold, both 
with and without NECA. 
Cytosolic Ca2+ levels of the mast cells were determined 
with the fluorescent indicator quin-2 (Fig. 3). Addition of Con 
A at 100 ILg/ml increased the fluorescence >2-fold, and 
subsequent quenching with 1 mM MnCh showed that only a 
minor proportion «10%) of this increase was due to extra-
cellular fluorescence from released quin-2. In the presence of 
10 ILM NECA this quin-2 signal was even slightly reduced. 
Three separate experiments gave an increase of cytosolic 
Ca2+ from 75 nM to 1300 nM under control conditions, and 
from 90 nM to 900 nM in the presence of 10 ILM NECA. These 
results indicate that the enhancement of histamine release by 
adenosine analogues occurs at a step subsequent to mobili-
zation of Ca2+ . 
Histamine release can be induced by low concentrations of 
Ca2+ after permeabilization by ATP (16). To test whether 
NECA enhances the sensitivity of the release process to 
Ca2+, we determined its effects on the Ca2+ -induced hista-
mine release in ATP-permeabilized mast cells (Fig. 4). Under 
these conditions 10 ILM NECA markedly enhanced the 
maximal effect of Ca2+ and shifted the concentration-re-
sponse curve to somewhat lower values. 
Similarly, when Ca2+ permeability of the cell membranes 
was achieved with the calcium ionophore A23187 (1ILM), 10 
Table 1. Effect of adenosine deaminase on histamine release 
from purified rat peritoneal mast cells 
Condition 
Basal 
Con A (0.1 mg/ml) 
A23187 (0.35 ILM) 
Histamine release, % of total 
Control 
4.4 ± 0.9 
12.8 ± 0.8 
35.7 ± 2.1 
Adenosine deaminase 
(2 units per ml) 
4.8 ± 0.7 
10.0 ± 1.1 
28.4 ± 2.5* 
Data represent the mean and SEM from six independent experi-
ments. 
*P < 0.05 vs. control. 
Biochemistry: Lohse et al. 
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FIG. 2. Enhancement of Con A-induced histamine release from rat peritoneal mast cells by NECA. Histamine release was measured in the 
presence oflO 1LM NECA (e) or buffer (0) after addition of Con A at 100 1Lg/ml. Inset, Concentration-response curve of Con A without or with 
10 1LM NECA. NECA (10 1LM) was added 10 min before stimulation with Con A (100 1Lg/ml added at t = 0). Histamine release was measured 
at the indicated time points or 10 min after addition of Con A. Concentration-response curves were fitted as in ref. 21, giving ECso values (95% 
confidence intervals) as follows: control, 29.0 mg/liter (22.0-38.3); NECA, 23.8 mg/liter (21.4-26.5) and giving maximal effects Emax (±SEM) 
as follows: control, 8.6 ± 0.4%; NECA, 16.3 ± 0.3%. Results are reported as the mean (±SEM) of three independent experiments. 
/-LM NECA shifted the EC50 value ofCa2+ from 720 /-LM (690-
760 /-LM) to 410 /-LM (380-440 /-LM) (means and 95% confidence 
limits, n = 3, P < 0.01). In the presence ofl mM Ca2+, finally, 
10 /-LM NECA shifted the EC50 value of A23187 from 0.36 /-LM 
(0.34-0.37) to 0.28 /-LM (0.27-0.29), P < 0.01. Maximal 
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release in these experiments was close to 100%, both with 
and without NECA, so that only an effect on the EC50 value 
of the stimulators was seen (data not shown). 
To test whether this enhancement of the sensitivity of the 
secretory process is selective for Ca2+, we also investigated 
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FIG. 3. Effect of NE CA on InsP3 (IP3) levels and cytosolic Ca2+ levels. Mast cells labeled with pH]inositol were preincubated with 10 1LM 
NECA (shaded bars) or buffer (open bars). The content ofPH]inositol phosphates was determined under basal conditions or 10 sec after addition 
of Con A at 100 1Lg/ml. Inositol bisphosphate levels (cpm/106 cells) in the same samples were as follows: basal control, 287 ± 32; basal NECA, 
334 ± 80; Con A control, 599 ± 56; Con A NECA, 580 ± 95. Data are reported as the mean and SEM from three independent experiments. 
Ca2+ levels were calculated from quin-2 fluorescence measurements as described. The time points between 0 and 5 sec (chamber opening for 
addition of Con A) are extrapolated by a straight line. Data are mean tracings from three independent experiments. 
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FIG. 4. Effect of 10 /LM NECA on Ca2+ -induced histamine 
release from ATp4--permeabilized mast cells . • , 10 /LM NECA; 0, 
buffer. ECso values and maximal effects (95% confidence limits and 
SEMs) were calculated as described (21): ECso control, 5.9/LM (5.1-
6.8/LM); NECA, 4.2/LM (3.9-4.6/LM); P < 0.05; Emax control, 4.9 
± 0.3%; NECA, 8.6 ± 0.2%; P < 0.01. Results are reported as the 
mean and SEM from three independent experiments. 
the stimulation of release by phorbol esters. Biologically 
active phorbol esters-i.e., those that stimulate protein 
kinase C (22), have been seen to stimulate histamine release 
at resting levels of cytosolic Ca2+ (4). By analogy to the 
stimulation of human neutrophil secretion by phorbol esters 
(23) this stimulation may be assumed to be largely Ca2+-
independent (6). Fig. 5 demonstrates that PMA-induced 
release of histamine was not significantly affected by 10 /LM 
NECA at any concentration of PMA. The other analogues of 
adenosine mentioned above also had no effect on PMA-
stimulated release. The biologically inactive 413-phorbol (24) 
failed to stimulate histamine release under all conditions (data 
not shown). Thus, adenosine analogues do not generally 
enhance sensitivity of the release process to stimuli but 
instead appear to specifically modulate Ca2+ sensitivity. 
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FIG. 5. Effect of 10 /LM NECA on PMA (TPA)-induced hista-
mine release from rat peritoneal mast cells . • , 10 /LM NECA; 0, 
buffer. NECA had no statistically significant effect on either ECso 
value or maximal effect of PMA. Results are reported as the mean 
and SEM from three independent experiments. 
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DISCUSSION 
Adenosine and several of its analogues have been shown to 
enhance histamine release from stimulated mast cells, but 
they do not induce release by themselves. In agreement with 
this observation, the present study demonstrates that the 
metabolically stable adenosine analogue NECA does not 
interfere with the first steps in the cascade from IgE-receptor 
activation to mediator release: Neither inositol phosphate 
generation nor cytosolic Ca2+ levels were affected by NECA 
in concentrations that caused maximal enhancement of 
histamine release. The lack of effect of NECA on phorbol 
ester-induced release reveals that the release process is not 
affected per se and indicates that the effect of adenosine 
occurs at a step linking elevated cytosolic Ca2+ concentra-
tions to mediator release. 
In fact, NECA increases the sensitivity of the release 
process to Ca2+, regardless of whether elevated Ca2+ levels 
are caused by IgE-receptor activation, by Ca2+ in ATP-
permeabilized cells, or by calcium ionophore A23187. Under 
any of these conditions, maximally effective concentrations 
of NECA more than doubled the release of histamine. 
It is unlikely that metabolism of adenosine is necessary for 
this effect, because the metabolically stable N 6_, 2-, and 
5' -substituted adenosine derivatives were all equally effec-
tive. From studies of the adenosine metabolizing enzymes 
(25-27) it appears equally unlikely that an inhibition of 
adenosine metabolism is responsible, because none of these 
enzymes are significantly inhibited by micro molar concen-
trations of adenosine or adenosine analogues. An interfer-
ence with cAMP-dependent inhibition of mediator release 
also seems unlikely, because adenosine interferes with 
cAMP-dependent protein kinase only at concentrations con-
siderably higher than those used in this study (28). 
Intracellular concentrations of adenosine in stimulated 
mast cells are sufficiently high to markedly enhance hista-
mine release (Fig. 1). Even under the diluted conditions ofthe 
in vitro experiment, removal of extracellular adenosine (also 
assumed to reduce intracellular adenosine concentrations) 
reduces stimulated histamine release. These effects of endog-
enous adenosine are not seen at basal or very low levels of 
histamine release, which suggests either that the stimulated 
cells are more sensitive to the effects of adenosine or that 
more adenosine is present in stimulated cells. 
From experiments with permeabilized neutrophils Gom-
perts and colleagues (6, 7) have proposed the existence of an 
intracellular guanine nucleotide-binding protein, termed Ge, 
linking release to cytosolic Ca2+ and possibly other intracel-
lular signals. More recently, the same authors have demon-
strated that in streptolysin-O-permeabilized mast cells acti-
vation of the release process requires both Ca2+ and GTP 
(29). Although ATP (1 mM) could not substitute for GTP, 
ATP increased the sensitivity of the release process to Ca2+ 
and GTP. The authors speculated that this result might 
indicate involvement of phosphoproteins in the release pro-
cess. Our data show that adenosine and several of its 
nonphosphorylated analogues have an effect similar to that of 
ATP, but even at micromolar concentrations. Perhaps all 
these compounds regulate sensitivity ofthe release process to 
cytosolic Ca2+ via Ge or a site in connection with Ge . 
An as yet unidentified signal that acts synergistically with 
Ca2+ to produce mast cell mediator release has been postu-
lated by Beaven et al. (30) and Penner and Neher (31). It 
seems possible that intracellular adenosine represents such a 
signal. 
In summary, our data show that adenosine increases the 
Ca2+ sensitivity of the release process in rat peritoneal mast 
cells. The intracellular concentration of adenosine in mast 
cells seems sufficient to regulate histamine release. These 
observations show an additional, physiologically relevant 
Biochemistry: Lohse et al. 
level of regulation of mast cell mediator release at a step distal 
to receptor activation and second-messenger generation. 
This level of intracellular regulation might become a target for 
the development of antiallergic drugs. 
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